Naomi Kelman
Naomi Kelman has been a director since September 2020. Ms. Kelman most recently served as President and Chief Executive Officer of Willow, a revolutionary new women’s health company, having served in that role from 2014 to 2019. From 2011 to 2012, Ms. Kelman served as the Global Division Head of Novartis OTC. Prior to that, Ms. Kelman served in a number of executive roles during her time at Johnson & Johnson from 2000 to 2011, including as President of Vistakon Americas (Acuvue contact lenses) from 2004 to 2009 and as President of LifeScan (OneTouch diabetes monitor) from 2009 to 2011. Before joining J&J, Ms. Kelman worked at Clairol, where she worked on a broad range of CPG personal care categories and was based in Europe for five years. Ms. Kelman started her career in finance at American Express. Ms. Kelman is a member of the board of directors of Mirvie, a biotechnology company. She also is on the board of directors and serves as chair of the board of Blue River PetCare, a leading operator of veterinary hospitals. Ms. Kelman has a Bachelor of Arts degree and an M.B.A. from Cornell University.